This activity is hosted on the site of our educational partner
You will be connecting to our educational partner, which controls its own content, practices, and other policies.
You will be connecting to our educational partner, which controls its own content, practices, and other policies.
Identifying and Addressing Persistent Hyperuricemia in Gout
Powered by
Format
Webcast
Time to Complete
1 hour
Released
December 21, 2017
Expires
December 20, 2018
Maximum Credits
1.00 / AMA PRA Category 1 Credit(s)TM
1.00 / CNE for Nurses
1.00 / CNE for Nurses
Accredited Provider
This activity is provided by Haymarket Medical Education (HME) for physician credit.
This activity is jointly provided by Global Education Group and HME for nursing contact hours.
This activity is jointly provided by Global Education Group and HME for nursing contact hours.
Commercial Supporter
Supported by Ironwood Pharmaceuticals, Inc.
Program Description
Gout is most often diagnosed and managed in the primary care setting, with referral to specialty care as required. Hyperuricemia underlies gout and has been linked to a host of potentially serious sequelae. However, despite a number of recent advances in gout management, many patients still do not achieve adequate control of serum uric acid levels. In addition, discordance between evidence-based guidelines from major medical organizations regarding the optimal treatment of gout has led to confusion and controversy.
To help bridge persistent practice gaps, this educational activity will feature an in-depth discussion of the potential effects of uncontrolled hyperuricemia. Strategies for managing hyperuricemia beyond acute gout attacks will be described. Available and emerging urate-lowering therapy will be discussed in detail. The faculty will review the importance of educating patients with gout about the potential effects of hyperuricemia and the importance of long-term adherence to help mitigate these effects.
To help bridge persistent practice gaps, this educational activity will feature an in-depth discussion of the potential effects of uncontrolled hyperuricemia. Strategies for managing hyperuricemia beyond acute gout attacks will be described. Available and emerging urate-lowering therapy will be discussed in detail. The faculty will review the importance of educating patients with gout about the potential effects of hyperuricemia and the importance of long-term adherence to help mitigate these effects.
Intended Audience
Primary care and internal medicine clinicians (MDs/DOs, physician assistants [PAs], nurse practitioners [NPs] and nurses); rheumatologists.
Educational Objectives
After completing the activity, the participant should be better able to:
- Describe the complications associated with uncontrolled hyperuricemia
- Review markers for quality care in patients with gout
- Discuss available and emerging options for urate-lowering therapy
- Implement effective treatment in patients with hyperuricemia
Conflict Of Interest Disclosure Policy
In accordance with the ACCME Standards for Commercial Support, Haymarket Medical Education (HME) and Global Education Group require that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. HME and Global Education resolve all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational activities.
Faculty
Michael Pillinger, MD
Chief of Rheumatology, VA NY Harbor Health Care System
Director, Clinical and Translational Science Institute Education and Careers Unit
New York University
New York, NY
Dr. Pillinger is a consultant to Horizon Pharmaceuticals and Ironwood Pharmaceuticals, Inc.
Naomi Schlesinger, MD
Professor of Medicine
Chief, Division of Rheumatology
Department of Medicine
Rutgers – Robert Wood Johnson Medical School
New Brunswick, NJ
Dr. Schlesinger receives grant/research support from AstraZeneca, is a consultant to BMS, Novartis, and Sobi, Inc., and receives honoraria from AstraZeneca, Celgene, Horizon, ProteoThera, Inc., and Pfizer.
Chief of Rheumatology, VA NY Harbor Health Care System
Director, Clinical and Translational Science Institute Education and Careers Unit
New York University
New York, NY
Dr. Pillinger is a consultant to Horizon Pharmaceuticals and Ironwood Pharmaceuticals, Inc.
Naomi Schlesinger, MD
Professor of Medicine
Chief, Division of Rheumatology
Department of Medicine
Rutgers – Robert Wood Johnson Medical School
New Brunswick, NJ
Dr. Schlesinger receives grant/research support from AstraZeneca, is a consultant to BMS, Novartis, and Sobi, Inc., and receives honoraria from AstraZeneca, Celgene, Horizon, ProteoThera, Inc., and Pfizer.
Accredited Provider Disclosures
The planners, managers, and reviewers for this program reported the following financial relationships with commercial interests whose products or services may be related to the content of this CME activity:
HME planners, managers, and reviewers have no relevant financial relationships to disclose.
Global Education Group planners: Ashley Marostica, RN, MSN, Lindsay Borvansky, and Liddy Knight have nothing to disclose.
HME planners, managers, and reviewers have no relevant financial relationships to disclose.
Global Education Group planners: Ashley Marostica, RN, MSN, Lindsay Borvansky, and Liddy Knight have nothing to disclose.
Publishing Staff Disclosures
Susan Basilico and Krista Sierra have nothing to disclose in regard to commercial support.
Credit
1.00
Type
AMA PRA Category 1 Credit(s)TM
Accreditation Statement
Haymarket Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation Statement
Haymarket Medical Education designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Credit
1.00
Type
CNE Contact Hour(s)
Accreditation Statement
Global Education Group is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Designation Statement
This educational activity for 1.00 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity. This activity is jointly provided by Global Education Group and Haymarket for ANCC credit.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. HME and Global Education Group do not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Ironwood, Global Education Group, and Haymarket Medical Education. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Instructions
In order to receive credit for this activity, the participant must complete the pre-activity questionnaire, post-test, and program evaluation. Participants must also score at least 70% on the post-test. Certificates will be distributed online at the conclusion of the activity. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.
If you have any questions relating to the accreditation of this activity, please contact cmequestions@haymarketmedical.com.
For information about the nursing accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.
If you have any other questions relating to your certificate or other issues with the activity, please contact
myCME.Support@haymarketmedical.com.
If you have any questions relating to the accreditation of this activity, please contact cmequestions@haymarketmedical.com.
For information about the nursing accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.
If you have any other questions relating to your certificate or other issues with the activity, please contact
myCME.Support@haymarketmedical.com.
Privacy Policy
SYSTEM REQUIREMENTS
Hardware and Software Requirements
- A computer with an internet connection
- Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
- Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Related to this activity
Sponsored Links